Clinical Trial Update: ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ITGA6-targeted NIR-II fluorescence image-guided surgery in hepatocellular carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ITGA6-targeted NIR-II fluorescence imaging agent (ITGA6-targeted NIR-II imaging probe)

Snippet

Sponsor: Institute of Automation, Chinese Academy of Sciences | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING